Fraunhofer Institute for Interfacial Engineering and Biotechnology IGBSuccessful translation into clinical practice
Over eight years ago, we embarked on a journey together with Fraunhofer IGB’s In-vitro Diagnostics innovation field, headed by Dr. Kai Sohn, to significantly optimize pathogen diagnostics in patients with sepsis, something that is also colloquially known as blood poisoning.
In a multi-step bench-to-bedside approach, technology based on next-generation sequencing (NGS) was further developed from the initial proof of concept to a commercially available diagnostic product that has now become part of clinical routines.
This success story was only possible because scientists from the clinic and researchers from Fraunhofer IGB played an equal part in the project and shared the goal of wanting to improve care for patients with sepsis.
Thorsten Brenner